Long COVID answers are coming into focus, slowly
Long COVID continues to offer more questions than answers 27 months into the coronavirus pandemic, though researchers are slowly gaining a better understanding. Below are some common questions and answers related to long COVID. While the sample size was limited -- 138 individuals with COVID, of which 48 reported long COVID -- it matched or followed trends found in other studies. “That being said, there’s a lot of people who’ve had mild COVID cases who have had issues with long COVID as well. A majority of respondents said they needed to take medical leave due to long COVID symptoms.
mlive.comModerna president: 4th vaccine dose only necessary for certain groups
A fourth dose of the COVID-19 vaccine will likely only be necessary for elderly and immunocompromised people but not for the general public, Moderna president Stephen Hoge told Business Insider on Monday.Why it matters: His words are in contrast to Pfizer CEO Albert Bourla's comments on Sunday, who said that fourth doses will be necessary in order to maintain manageable levels of hospitalizations and mild infections.Stay on top of the latest market trends and economic insights with Axios Markets
news.yahoo.comCases of ‘long COVID’ frustrate patients, puzzle scientists
If even a tiny fraction of them develop long COVID, they will probably present a massive challenge to healthcare systems. Long COVID sufferers “have stepped forward ahead of the scientists,” said Dr. Harlan Krumholz, director of Yale’s Center for Outcomes Research & Evaluation. Iwasaki is a revered figure among long COVID patients. Akiko Iwasaki, an immunobiologist at Yale, is revered by Long COVID patients because she takes their condition seriously. AdvertisementThis could explain why roughly a third of long COVID patients improved after getting a dose or two of COVID-19 vaccines.
latimes.comCan vaccines help long-haul COVID-19 sufferers?
"We don't necessarily have a definition yet of long COVID," he said, "... a lot more theories than clear science." Fauci touted a $1.15 billion appropriation given to the National Institutes of Health specifically to study long COVID on Wednesday. The study — which has yet to be peer reviewed — concluded that "individuals with prolonged COVID-19 symptoms should receive vaccinations as suggested by national guidance." "(We) focus on what their specific symptoms are and how their life is affected by those symptoms," Maley said. The gamut of symptoms mean that long COVID patients end up seeing a variety of doctors.
cbsnews.com